Floatz logo

Rhil-7

Lymphoma, Non-hodgkins

Medical College of WisconsinPhase 1/2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Lymphoma, Non-hodgkins cohort.

Asset / SponsorPhaseRating
INTERLEUKIN-21
National Cancer Institute (NCI)
Phase 1CC
C-Car066
National Cancer Institute (NCI)
Phase 1CC

Same molecule, other indications

Rhil-7 is also rated in:

B-cell non-Hodgkin lymphomaDormant
B
Indicative ·
62 / 100
View asset →
breast cancerDormant
CCC
Indicative ·
54 / 100
View asset →
embryonal rhabdomyosarcomaDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →